CD4 and cutaneous mastocytosis: At CM-IRIS, the frequency of CD4+ T cells expressing HLA-DR was significantly decreased compared to CM diagnosis, 66% (IQR, 60%–79%) vs. 81% (IQR, 66%–90%), (p = 0.014) respectively.